PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3286349-0	1988	Insulin-glycerolipid mediators and gene expression.	glycerolipid	8-20	insulin	Homo sapiens	0-7	
3288620-10	1988	These results establish a central role for insulin-induced glycerolipid metabolism in mediating insulin-stimulated glucose transport in BC3H-1 myocytes.	glycerolipid	59-71	insulin	Homo sapiens	43-50	
3288620-10	1988	These results establish a central role for insulin-induced glycerolipid metabolism in mediating insulin-stimulated glucose transport in BC3H-1 myocytes.	glycerolipid	59-71	insulin	Homo sapiens	96-103	
2653913-0	1989	Role of insulin and counter-regulatory hormones in the control of hepatic glycerolipid synthesis and low-density-lipoprotein catabolism in diabetes.	glycerolipid	74-86	insulin	Homo sapiens	8-15	
3288620-0	1988	Insulin-induced glycerolipid mediators and the stimulation of glucose transport in BC3H-1 myocytes.	glycerolipid	16-28	insulin	Homo sapiens	0-7	
3288620-1	1988	We have previously demonstrated that insulin stimulates glycerolipid synthesis and phospholipid hydrolysis in BC3H-1 myocytes, resulting in the generation of membrane diacylglycerol, a known cellular mediator.	glycerolipid	56-68	insulin	Homo sapiens	37-44	
3286349-4	1988	In this review, we explore the involvement of insulin-induced changes in plasma membrane glycerolipid metabolism in the transmembrane signaling process required for insulin regulation of mRNA levels.	glycerolipid	89-101	insulin	Homo sapiens	46-53	
3286349-4	1988	In this review, we explore the involvement of insulin-induced changes in plasma membrane glycerolipid metabolism in the transmembrane signaling process required for insulin regulation of mRNA levels.	glycerolipid	89-101	insulin	Homo sapiens	165-172	
26755581-1	2016	Obesity, and the associated disturbed glycerolipid/fatty acid (GL/FA) cycle, contribute to insulin resistance, islet beta-cell failure, and type 2 diabetes.	glycerolipid	38-50	insulin	Homo sapiens	91-98	
25210878-4	2014	OBJECTIVE: To test the hypothesis that ISO and body mass index-matched insulin-resistant obese (IRO) patients demonstrate differential SAT expression profiles of genes involved in glycerolipid-FA metabolism and that weight loss-induced improvement of IR ameliorates these changes.	glycerolipid	180-192	insulin	Homo sapiens	71-78	
20181984-9	2010	Our results reveal a link between the lipogenic effects of insulin and microsomal GPAT3 and GPAT4, implying their importance in glycerolipid biosynthesis.	glycerolipid	128-140	insulin	Homo sapiens	59-66